C5orf22
gene geneOn this page
Also known as FLJ11193
Summary
C5orf22 (chromosome 5 open reading frame 22, HGNC:25639) is a protein-coding gene on chromosome 5p13.3, encoding UPF0489 protein C5orf22 (Q49AR2).
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 20 total — 1 pathogenic
- MANE Select transcript:
NM_018356
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25639 |
| Approved symbol | C5orf22 |
| Name | chromosome 5 open reading frame 22 |
| Location | 5p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ11193 |
| Ensembl gene | ENSG00000082213 |
| Ensembl biotype | protein_coding |
| Entrez | 55322 |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 4 nonsense_mediated_decay, 3 protein_coding, 2 protein_coding_CDS_not_defined, 2 retained_intron
ENST00000325366, ENST00000504464, ENST00000504866, ENST00000507818, ENST00000510530, ENST00000510659, ENST00000511208, ENST00000513967, ENST00000515409, ENST00000517780, ENST00000926221
RefSeq mRNA: 1 — MANE Select: NM_018356
NM_018356
CCDS: CCDS3895
Canonical transcript exons
ENST00000325366 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001844074 | 31552773 | 31555053 |
| ENSE00003525421 | 31538260 | 31538689 |
| ENSE00003555735 | 31551293 | 31551432 |
| ENSE00003643718 | 31541281 | 31541402 |
| ENSE00003644259 | 31532301 | 31532473 |
| ENSE00003649458 | 31540949 | 31541011 |
| ENSE00003667586 | 31545646 | 31545712 |
| ENSE00003691445 | 31534272 | 31534417 |
| ENSE00003786752 | 31535744 | 31535893 |
Expression profiles
Bgee: expression breadth ubiquitous, 287 present calls, max score 98.08.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 18.9827 / max 239.3115, expressed in 1813 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 55964 | 18.9576 | 1813 |
| 55965 | 0.0251 | 7 |
Top tissues by expression
294 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| secondary oocyte | CL:0000655 | 98.08 | gold quality |
| oocyte | CL:0000023 | 94.61 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 91.13 | gold quality |
| biceps brachii | UBERON:0001507 | 90.86 | gold quality |
| hair follicle | UBERON:0002073 | 89.28 | silver quality |
| mucosa of sigmoid colon | UBERON:0004993 | 89.16 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 89.03 | gold quality |
| colonic mucosa | UBERON:0000317 | 88.84 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 87.91 | gold quality |
| calcaneal tendon | UBERON:0003701 | 87.59 | gold quality |
| gastrocnemius | UBERON:0001388 | 87.03 | gold quality |
| muscle of leg | UBERON:0001383 | 87.01 | gold quality |
| choroid plexus epithelium | UBERON:0003911 | 86.93 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 86.92 | gold quality |
| muscle organ | UBERON:0001630 | 86.91 | gold quality |
| muscle tissue | UBERON:0002385 | 86.84 | gold quality |
| heart right ventricle | UBERON:0002080 | 86.75 | gold quality |
| deltoid | UBERON:0001476 | 86.56 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 86.46 | gold quality |
| vastus lateralis | UBERON:0001379 | 86.26 | silver quality |
| bone marrow cell | CL:0002092 | 86.05 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 85.69 | gold quality |
| tibialis anterior | UBERON:0001385 | 85.66 | gold quality |
| myocardium | UBERON:0002349 | 85.62 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 85.52 | gold quality |
| adrenal tissue | UBERON:0018303 | 85.47 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.36 | gold quality |
| embryo | UBERON:0000922 | 85.34 | gold quality |
| bone marrow | UBERON:0002371 | 85.28 | gold quality |
| CA1 field of hippocampus | UBERON:0003881 | 85.27 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.93 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): E2F4
miRNA regulators (miRDB)
129 targeting C5orf22, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-4668-3P | 100.00 | 68.74 | 2635 |
| HSA-MIR-3667-3P | 99.99 | 67.17 | 1636 |
| HSA-MIR-6077 | 99.99 | 68.04 | 2299 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-433-3P | 99.98 | 69.37 | 1203 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
| HSA-MIR-512-3P | 99.97 | 67.35 | 1049 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-96-5P | 99.95 | 72.80 | 2140 |
| HSA-LET-7C-3P | 99.95 | 73.42 | 2862 |
| HSA-MIR-545-3P | 99.95 | 70.74 | 2783 |
| HSA-MIR-559 | 99.95 | 72.28 | 3609 |
| HSA-MIR-548AB | 99.95 | 71.31 | 3488 |
| HSA-MIR-548A-5P | 99.94 | 71.27 | 3482 |
| HSA-MIR-548AD-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AE-5P | 99.94 | 71.23 | 3502 |
Literature-anchored findings (GeneRIF, showing 1)
- A Proteomic Connectivity Map for Characterizing the Tumor Adaptive Response to Small Molecule Chemical Perturbagens. (PMID:31846293)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | C2H5orf22 | ENSDARG00000011723 |
| mus_musculus | 6030458C11Rik | ENSMUSG00000022195 |
| rattus_norvegicus | C2h5orf22 | ENSRNOG00000022745 |
| drosophila_melanogaster | MESR6 | FBGN0036846 |
Protein
Protein identifiers
UPF0489 protein C5orf22 — Q49AR2 (reviewed: Q49AR2)
All UniProt accessions (4): Q49AR2, B4DR92, E5RFG1, E5RHP8
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the UPF0489 family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q49AR2-1 | 1 | yes |
| Q49AR2-2 | 2 | |
| Q49AR2-3 | 3 |
RefSeq proteins (1): NP_060826* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR024131 | FlmR/OhkR-like | Family |
Pfam: PF12640
UniProt features (9 total): splice variant 3, sequence variant 2, chain 1, region of interest 1, compositionally biased region 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q49AR2-F1 | 85.16 | 0.75 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 110 (showing top):
RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP, IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR, MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP, WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN, RYTTCCTG_ETS2_B, GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS, BIDUS_METASTASIS_UP, MARSON_BOUND_BY_E2F4_UNSTIMULATED, BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP, BROWNE_HCMV_INFECTION_48HR_UP, STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP, JOHNSTONE_PARVB_TARGETS_3_DN, TERAO_AOX4_TARGETS_SKIN_DN, PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN, LIM_MAMMARY_STEM_CELL_DN
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
1000 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| C5orf22 | SAYSD1 | Q9NPB0 | 580 |
| C5orf22 | TPGS2 | Q68CL5 | 562 |
| C5orf22 | TRMT13 | Q9NUP7 | 541 |
| C5orf22 | RGS3 | P49796 | 537 |
| C5orf22 | TRPM6 | Q9BX84 | 455 |
| C5orf22 | PRR3 | P79522 | 448 |
| C5orf22 | PIGH | Q14442 | 437 |
| C5orf22 | BDNF | P23560 | 429 |
| C5orf22 | NXT2 | Q9NPJ8 | 424 |
| C5orf22 | TMEM267 | Q0VDI3 | 397 |
| C5orf22 | SPANXN1 | Q5VSR9 | 397 |
| C5orf22 | SPRYD7 | Q5W111 | 370 |
| C5orf22 | IFFO1 | Q0D2I5 | 368 |
| C5orf22 | ZNF250 | P15622 | 366 |
| C5orf22 | SPRING1 | Q9H741 | 350 |
IntAct
33 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| C5orf22 | WBP11 | psi-mi:“MI:0915”(physical association) | 0.800 |
| WBP11 | PQBP1 | psi-mi:“MI:0914”(association) | 0.800 |
| SURF2 | RPL5 | psi-mi:“MI:0914”(association) | 0.800 |
| WBP11 | C5orf22 | psi-mi:“MI:0915”(physical association) | 0.800 |
| OSM | IL6ST | psi-mi:“MI:0914”(association) | 0.760 |
| ELOF1 | C5orf22 | psi-mi:“MI:0915”(physical association) | 0.670 |
| C5orf22 | ELOF1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| C5orf22 | DDIT4L | psi-mi:“MI:0915”(physical association) | 0.560 |
| XAGE1A | THAP12 | psi-mi:“MI:0914”(association) | 0.530 |
| SURF2 | HEXIM1 | psi-mi:“MI:0914”(association) | 0.530 |
| NOL9 | IPO5 | psi-mi:“MI:0914”(association) | 0.530 |
| SURF2 | KPNA6 | psi-mi:“MI:0914”(association) | 0.350 |
| DEF8 | DPYSL4 | psi-mi:“MI:0914”(association) | 0.350 |
| WBP11 | PQBP1 | psi-mi:“MI:0914”(association) | 0.350 |
| CDC14B | PPP1R12A | psi-mi:“MI:0914”(association) | 0.350 |
| SPON1 | AHCYL1 | psi-mi:“MI:0914”(association) | 0.350 |
| CTAG2 | PCNT | psi-mi:“MI:0914”(association) | 0.350 |
| NOBOX | CDK2 | psi-mi:“MI:0914”(association) | 0.350 |
| FOXE3 | C1QBP | psi-mi:“MI:0914”(association) | 0.350 |
| PQBP1 | ANK3 | psi-mi:“MI:0914”(association) | 0.350 |
| PQBP1 | C5orf22 | psi-mi:“MI:0914”(association) | 0.350 |
| C5orf22 | ELOF1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| C5orf22 | DDIT4L | psi-mi:“MI:0915”(physical association) | 0.000 |
| C5orf22 | WBP11 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (40): C5orf22 (Affinity Capture-MS), C5orf22 (Affinity Capture-MS), ELOF1 (Two-hybrid), C5orf22 (Two-hybrid), C5orf22 (Affinity Capture-MS), C5orf22 (Affinity Capture-MS), C5orf22 (Affinity Capture-MS), C5orf22 (Affinity Capture-MS), C5orf22 (Affinity Capture-MS), C5orf22 (Negative Genetic), C5orf22 (Synthetic Lethality), C5orf22 (Affinity Capture-MS), WBP11 (Two-hybrid), ELOF1 (Two-hybrid), DDIT4L (Two-hybrid)
ESM2 similar proteins: A2AUU0, A3KMI0, E7F654, F1MAB7, P33279, P59114, Q08DH3, Q0P5B2, Q13686, Q28H30, Q3T131, Q3T9Z9, Q49AR2, Q4R8E0, Q5R5W9, Q5R6T6, Q5U2S3, Q5ZLL7, Q62240, Q63185, Q6DTM3, Q6NXH8, Q6NZP1, Q6P1Q9, Q6PAE6, Q6PD74, Q6ZUJ8, Q7SZF1, Q7TNN8, Q7Z3E5, Q8BGC1, Q8BMD7, Q8BMK1, Q8CHK4, Q8K3E5, Q8N6Q8, Q8TE76, Q8W5R2, Q92993, Q96IZ6
Diamond homologs: Q28H30, Q49AR2, Q5R5W9, Q6PAE6, Q7SZF1, Q8BGC1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
20 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 5 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 147643 | GRCh38/hg38 5p13.3(chr5:31208753-32173244)x3 | Pathogenic |
SpliceAI
1623 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 5:31534269:CAGGT:C | acceptor_loss | 1.0000 |
| 5:31534270:A:AG | acceptor_gain | 1.0000 |
| 5:31534270:A:C | acceptor_loss | 1.0000 |
| 5:31534271:G:GG | acceptor_gain | 1.0000 |
| 5:31534271:GGTT:G | acceptor_gain | 1.0000 |
| 5:31534321:GTAAT:G | donor_gain | 1.0000 |
| 5:31534326:G:GG | donor_gain | 1.0000 |
| 5:31535069:G:GT | donor_gain | 1.0000 |
| 5:31535070:A:T | donor_gain | 1.0000 |
| 5:31535742:A:AG | acceptor_gain | 1.0000 |
| 5:31535743:G:GG | acceptor_gain | 1.0000 |
| 5:31535743:GA:G | acceptor_gain | 1.0000 |
| 5:31535743:GAGA:G | acceptor_gain | 1.0000 |
| 5:31535890:TCAG:T | donor_loss | 1.0000 |
| 5:31535891:CAG:C | donor_loss | 1.0000 |
| 5:31535892:AGG:A | donor_loss | 1.0000 |
| 5:31535893:GGT:G | donor_loss | 1.0000 |
| 5:31535894:GT:G | donor_loss | 1.0000 |
| 5:31535895:T:A | donor_loss | 1.0000 |
| 5:31538258:AG:A | acceptor_gain | 1.0000 |
| 5:31538259:GG:G | acceptor_gain | 1.0000 |
| 5:31538617:G:T | donor_gain | 1.0000 |
| 5:31541008:AGAGG:A | donor_loss | 1.0000 |
| 5:31541009:GAG:G | donor_gain | 1.0000 |
| 5:31541009:GAGG:G | donor_loss | 1.0000 |
| 5:31541011:GGTAT:G | donor_loss | 1.0000 |
| 5:31541012:G:GA | donor_loss | 1.0000 |
| 5:31541013:T:A | donor_loss | 1.0000 |
| 5:31541401:GG:G | donor_gain | 1.0000 |
| 5:31541402:GG:G | donor_gain | 1.0000 |
AlphaMissense
2918 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 5:31535763:T:A | W83R | 0.998 |
| 5:31535763:T:C | W83R | 0.998 |
| 5:31538646:A:T | D255V | 0.998 |
| 5:31535823:T:A | W103R | 0.997 |
| 5:31535823:T:C | W103R | 0.997 |
| 5:31538646:A:C | D255A | 0.997 |
| 5:31538647:T:A | D255E | 0.997 |
| 5:31538647:T:G | D255E | 0.997 |
| 5:31551306:G:A | G358D | 0.997 |
| 5:31534345:A:T | D52V | 0.996 |
| 5:31534360:T:C | L57P | 0.996 |
| 5:31535808:T:A | W98R | 0.996 |
| 5:31535808:T:C | W98R | 0.996 |
| 5:31538665:T:A | N261K | 0.996 |
| 5:31538665:T:G | N261K | 0.996 |
| 5:31538669:T:C | F263L | 0.996 |
| 5:31538671:C:A | F263L | 0.996 |
| 5:31538671:C:G | F263L | 0.996 |
| 5:31552794:T:G | C407W | 0.996 |
| 5:31534338:C:G | H50D | 0.995 |
| 5:31534350:C:G | H54D | 0.995 |
| 5:31534357:A:T | D56V | 0.995 |
| 5:31535762:T:A | N82K | 0.995 |
| 5:31535762:T:G | N82K | 0.995 |
| 5:31538646:A:G | D255G | 0.995 |
| 5:31551294:T:A | V354D | 0.995 |
| 5:31551302:G:C | A357P | 0.995 |
| 5:31551303:C:A | A357D | 0.995 |
| 5:31534346:C:A | D52E | 0.994 |
| 5:31534346:C:G | D52E | 0.994 |
dbSNP variants (sampled 300 via entrez): RS1000130906 (5:31549779 G>A), RS1000210208 (5:31543126 C>A), RS1000267384 (5:31549392 C>G), RS1000448397 (5:31551332 C>T), RS1000660907 (5:31543477 G>A), RS1000946695 (5:31543902 T>C), RS1000986523 (5:31538075 G>A), RS1001039103 (5:31537563 C>G,T), RS1001053777 (5:31550608 C>A), RS1001147591 (5:31544511 A>G), RS1001515570 (5:31544378 T>C), RS1001770571 (5:31530419 A>T), RS1001921965 (5:31549921 A>T), RS1002011016 (5:31555323 A>C,G), RS1002108861 (5:31543009 GA>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006991_2 | Cerebrospinal fluid t-tau levels in Alzheimer’s disease dementia | 9.000000e-07 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004760 | t-tau measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
PharmGKB variants
1 variants.
| Variant | Genes | Level | Score | #Clin annots | Drugs |
|---|---|---|---|---|---|
| rs10035440 | C5orf22 | 0.00 | 0 |
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | decreases expression, increases expression | 2 |
| TAK-243 | increases sumoylation | 1 |
| geldanamycin | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| glycidyl methacrylate | decreases expression | 1 |
| trichostatin A | decreases expression | 1 |
| beta-lapachone | increases expression | 1 |
| potassium chromate(VI) | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Leflunomide | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Caffeine | decreases phosphorylation | 1 |
| Doxorubicin | decreases expression | 1 |
| Etoposide | affects response to substance | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.